Radiation oncology as a profession is in a period of retrenchment due to the economic crisis. There is also a growing demand from payors to show value for these treatments, said ASTRO President Anthony Zeitman, M.D. He says the technologies used need to undergo rigorous clinical testing to show what works best and what is most cost-effective.
If you enjoy this content, please share it with a colleague
- Read more about Trends in Radiation Oncology From ASTRO 2010
- Log in or register to post comments